Welcome to our dedicated page for British American Tobacco p.l.c. SEC filings (Ticker: BTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on British American Tobacco p.l.c.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into British American Tobacco p.l.c.'s regulatory disclosures and financial reporting.
British American Tobacco p.l.c. submitted a Form 6-K as a foreign private issuer to furnish two press releases dated April 9, 2026. One announces that BAT has appointed a Chief Financial Officer. The other provides notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
The filing also states that most of the information in Exhibit 1 is incorporated by reference into several existing Form S-8 and Form F-3 registration statements and related prospectuses for BAT and its affiliated issuers.
British American Tobacco reports extensive March 2026 capital-market activity, led by ongoing on-market share buybacks under its authority from the April 2025 AGM.
On 27 February 2026 the company repurchased 93,337 ordinary shares of 25p each at a volume‑weighted average price of 4,617.6633p, and planned to cancel them, leaving 2,174,735,544 ordinary shares in issue and 132,976,327 held in treasury. Additional purchases included 92,891 shares on 2 March 2026 at 4,639.8420p, 94,660 shares on 3 March at 4,553.1176p, and 95,178 shares on 4 March at 4,528.3542p, all intended for cancellation.
A separate voting rights update states that as at 27 February 2026 the issued share capital with voting rights was 2,174,922,198 shares and 132,976,327 shares were held in treasury. The filing also discloses small purchases of ordinary shares by the Chief Executive and other senior managers under a U.K. tax‑advantaged Share Incentive Plan at £45.03191 per share.
British American Tobacco submitted a Form 25 notification via the New York Stock Exchange to remove from listing the class described as the "Guarantor of the 1.668% Notes due 2026." The Exchange and the issuer each certified compliance with 17 CFR 240.12d2-2 in effecting the removal.
British American Tobacco p.l.c. submitted a Form 6-K as a foreign private issuer, making available materials published as of March 10, 2026. The filing primarily forwards a press release titled “British American Tobacco p.l.c. - Notice of Annual General Meeting 2026” dated March 10, 2026 as an exhibit.
British American Tobacco p.l.c. reports a series of routine capital and governance updates, mainly focused on share buybacks and small executive share acquisitions. Under its existing buyback programme, the company repurchased 125,526 shares on 30 January 2026 at a volume‑weighted average price of 4,355.1405p, with further daily purchases including 108,725 shares on 2 February, 117,545 on 3 February, 136,167 on 4 February, 121,668 on 5 February and 131,297 on 6 February 2026. These shares are intended to be cancelled, leaving 2,176,273,303 ordinary shares in issue excluding treasury after the 6 February trades, while 132,976,327 shares are held in treasury. A separate voting rights notice states that, as at 30 January 2026, issued share capital with voting rights totalled 2,177,145,903 shares. Several senior executives and other managers acquired small numbers of shares, typically between 1 and 699 shares each, through the Share Incentive Plan, dividend reinvestment arrangements and deferred bonus schemes at prices around £45–£46 per share.